. 2003 Jul-Aug;22(7-8):1005-9.

Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V

Affiliations

Daniel Ferreira. Rev Port Cardiol. 2003 Jul-Aug.

. 2003 Jul-Aug;22(7-8):1005-9.

No abstract available

Similar articles

[Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
Franzosi MG. Franzosi MG. Ital Heart J Suppl. 2001 Sep;2(9):1034-6. Ital Heart J Suppl. 2001. PMID: 11675828 Italian. No abstract available.
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Pereira H; GUSTO V Investigators. Pereira H, et al. Rev Port Cardiol. 2001 Jun;20(6):687-8. Rev Port Cardiol. 2001. PMID: 11525077 No abstract available.
Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
Patel VB, Moliterno DJ. Patel VB, et al. J Invasive Cardiol. 2000 Mar;12 Suppl B:8B-15B. J Invasive Cardiol. 2000. PMID: 10731294 Review. No abstract available.
The GUSTO-V clinical trial.
Lincoff AM. Lincoff AM. J Invasive Cardiol. 2002 Feb;14 Suppl A:21A-30A. J Invasive Cardiol. 2002. PMID: 11847403 Clinical Trial. No abstract available.
Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: an emerging solution for reperfusion.
Kaplan AL, Goldmann B, Ohman EM. Kaplan AL, et al. J Emerg Med. 1999 May-Jun;17(3):589-95. doi: 10.1016/s0736-4679(99)00024-4. J Emerg Med. 1999. PMID: 10338261 Review. No abstract available.